While PET scans have been used to predict Hodgkin lymphoma outcomes, adding Adcetris to frontline therapy improved outcomes for patients, regardless of their results. Adding Adcetris (brentuximab ...

The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...

DEAR MAYO CLINIC: My father just started chemotherapy for lymphoma, and he is scheduled for a positron emission tomography, or PET scan, after his first three treatments. How do doctors decide when to ...

Circulating tumor DNA (ctDNA) minimal residual disease (MRD) assessment at treatment completion provides superior prognostic accuracy compared with PET in large B-cell lymphoma. The CLARITY assay ...

To evaluate the use of interim positron emission tomography-computed tomography (PET-CT) scans and Deauville 5-point scale (5PS) score reporting for stage III/IV classic Hodgkin lymphoma (cHL) treated ...

Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index ...

Early [¹⁸F]fluorodeoxyglucose (FDG) PET-CT assessment after one cycle of brentuximab vedotin-based chemotherapy in advanced‑stage classical Hodgkin lymphoma allowed selective treatment intensification ...

EOT Signatera-positivity was prognostic of significantly inferior event-free survival (EFS) (adj HR: 45.33; p<0.0001) and was the strongest independent predictor of EFS in a multivariate analysis (HR: ...

The correspondence by Meignan et al, entitled “Development and Application of a Real-Time On-Line Blinded Independent Central Review of Interim Pet Scans to Determine Treatment Allocation in Lymphoma ...